Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study

BACKGROUND: The aim of this study was to assess the efficacy and safety of a combination regimen of capecitabine plus cisplatin (CC) or capecitabine plus paclitaxel (CP) as a first-line treatment in patients with metastatic esophageal squamous cell carcinoma. METHODS: Patients with recurrent or meta...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Cancer
Main Authors: Lee, Su Jin, Kim, Sungmin, Kim, Moonjin, Lee, Jeeyun, Park, Yeon Hee, Im, Young-Hyuck, Park, Se Hoon
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2015
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4606554/
https://ncbi.nlm.nih.gov/pubmed/26468007
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1716-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki